Understand the key differences between biosimilars and generics. Learn why provider education matters, how to address common misconceptions, and strategies to improve adoption rates while reducing healthcare costs.
Biosimilars work just as well as original biologics for treating conditions like arthritis, Crohn’s, and cancer. Decades of data and real-world use confirm they’re safe, effective, and significantly cheaper.
Generic medications saved the U.S. healthcare system $467 billion in 2024 alone, with over $3.4 trillion saved since 2015. They make up 90% of prescriptions but only 12% of drug spending, proving they're the most powerful tool for lowering costs without sacrificing care.